DUBLIN, March 30, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it is publicly sharing the […]
Delivered 2019 annual revenues of $7.43 Million (94.1% increase)Total Adjusted EBITDA of $852,647 (249% increase)Launched next generation of Telehealth Platform […]
Recently Initiated PB2452 Phase 3 Trial for the Reversal of the Antiplatelet Effects of TicagrelorReceived FDA Breakthrough Therapy Designation and […]
WARREN, N.J., March 30, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing […]